CodaVax-H1N1

Codagenix: Flu can mutate, but it can’t hide

By GREGORY ZELLER // In a potentially huge breakthrough in the struggle against seasonal influenza mutations, Codagenix Inc. is preparing to release data demonstrating “multi-season efficacy” for its frontline flu vaccine – meaning the vaccine could prevent flu-related sicknesses even after the virus mutates. According to the Farmingdale-based clinical-stage startup, in multiple studies involving pigs and ferrets, CodaVax-H1N1 – Codagenx’s live-attenuated Influenza A vaccine – induced “a robust immune response to multiple seasonal strains of…